- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Henlius is honored to showcase the latest resultsfrom clinicaltrials at #ESMO Asia 2024 in Singapore
From 6 to 8 December 2024, the European Society for Medical Oncology Asia (ESMO Asia) Congress will be held in Singapore. At this congress, Henlius will share the latest results of clinical trials of several products, including HANSIZHUANG (serplulimab), HLX07 (anti-EGFR mAb), and daratumumab biosimilar HLX15.
Видео Henlius is honored to showcase the latest resultsfrom clinicaltrials at #ESMO Asia 2024 in Singapore канала Henlius
Видео Henlius is honored to showcase the latest resultsfrom clinicaltrials at #ESMO Asia 2024 in Singapore канала Henlius
Комментарии отсутствуют
Информация о видео
21 ноября 2024 г. 15:38:12
00:00:16
Другие видео канала
Henlius and Saudi Arabia’s SVAX signed a strategic partnership
Differentiated Characteristics in Molecular Structure and MOA of Serplulimab
Fierce Biotech: Inside Henlius’ Global Growth Strategy
Advancing HER2+ GC treatment
Henlius to Showcase Latest Results of Serplulimab at 2024 ASCO
HLX43: PD-L1 targeting ADC Mechanism
Henlius and Sermonix Announce Strategic Collaboration
Henlius 2023 Annual Results
Henlius' 2025 H1 Results Announced
2025 Henlius R&D Day
We define a partner of choice, and we desire to become yours.
2023 H1 Financial Highlights
Henlius Releases 2022 ESG Report
Henlius 2024 Annual Results: RMB820M Net Profit, +50% YoY
Henlius to Release Clinical Data at 2024 ASCO GI
HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC
Henlius Enters Exclusive License Agreement with Lotus for Anti-PD-1 mAb Serplulimab in South Korea
Henlius and Convalife Reach Global Strategic Cooperation on Neratinib
EMA Validates Henlius and Organon Filing for Another Self-developed Biosimilar Candidate
Henlius to Present Latest Clinical Data of HLX10 and HLX22 at 2025 ASCO GI
